China Regenerative Medicine International Ltd. is an investment holding company, which engages in in research and development of medical and healthcare products. It operates through the following segments: Dermatology and Others; Cosmetic Products and Services; Cell Products and Services; Healthcare Products and Services; Ophthalmology Products; and Stomatology Products and Others. The Dermatology and Others segment includes production and sale of dermatology products and services and trading of medical equipment. The Cosmetic Products and Services segment produces and sells cosmetic products and services. The Cell Products and Services segment comprises of production and sales of cell and healthcare products and services. The Healthcare Products and Services segment includes production and sale of healthcare products and services. The Ophthalmology Products segment consists of production and sales of ophthalmology products. The Stomatology Products and Others segment focuses on the production and sale of stomatology products and others. The company was founded on April 20, 2001 and is headquartered in Hong Kong.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company